Browse the evidence

Tirzepatide effectively attenuated the rewarding properties of alcohol, measured through locomotor stimulation, conditioned place preference, and accumbal dopamine release.

Tirzepatide may be a potential treatment for reducing alcohol consumption and its rewarding effects.

In women with type 2 diabetes, cardiovascular autonomic neuropathy (CAN) is significantly associated with an increased risk of all-cause mortality (CAN1: HR 1.64, CAN2: HR 1.58, CAN3: HR 1.78) and cardiovascular disease mortality (CAN1: HR 2.25, CAN2: HR 2.22, CAN3: HR 3.31).

Healthcare providers should prioritize monitoring CAN in women with type 2 diabetes to mitigate mortality risk.

Sugar-sweetened beverage companies have successfully marketed their products by associating them with global cultural and sporting events.

Awareness of marketing tactics can help consumers make informed choices about beverage consumption.

The BB-Health study will evaluate age-sensitive cognitive assessments and cerebral hemodynamics as outcomes.

Practitioners should monitor cognitive health and cerebral hemodynamics in interventions.

GLP-1 receptor agonists (GLP-1RAs) may have neuroprotective and neurotrophic effects in ALS models.

GLP-1RAs may be considered for further investigation in ALS treatment.

Preoperative screening and interdisciplinary coordination are important for patients using GLP-1 RAs undergoing ophthalmic surgery.

Healthcare teams should ensure thorough preoperative assessments for these patients.

Patients who failed to complete outstanding program requirements were significantly more likely to be involved in outpatient behavioral health treatment.

Practitioners should consider the mental health status of patients when assessing their likelihood of completing bariatric surgery.

Patients with outstanding program requirements had a higher likelihood of taking psychotropic medications.

Awareness of psychotropic medication use can inform treatment plans for patients in bariatric programs.

rCBF decreases in the hypothalamus and thalamus were attenuated in obese men compared with lean men.

This finding suggests that interventions may need to address specific brain region responses in obesity.

Obese women exhibited significantly greater increases in rCBF in the ventral prefrontal cortex compared to lean women.

This finding suggests that interventions targeting the ventral prefrontal cortex may differ based on obesity status.

Integration of HEPAS with pharmacological and psychological therapies is essential for managing neuropsychiatric disorders.

Clinicians should ensure that lifestyle interventions are part of a comprehensive treatment plan.

The prediction models can differentiate solid foods from liquids with >91% accuracy.

This indicates that the method can accurately classify food types.

Increasing levels of neurofilament light chain (NfL) are associated with worsening cognitive function and incident mild cognitive impairment or probable dementia.

Monitoring NfL levels may help in assessing cognitive decline in patients with T2D and obesity.

Increasing levels of glial fibrillary acidic protein (GFAP) are associated with worsening cognitive function and incident mild cognitive impairment or probable dementia.

Tracking GFAP levels may provide insights into cognitive health in patients with T2D and obesity.

The intensive lifestyle intervention (ILI) did not result in preserved cognitive function or slower rates of cognitive decline in individuals with type 2 diabetes and overweight/obesity.

Practitioners should be cautious in expecting cognitive benefits from lifestyle interventions in this population.

There were no differences in the rate of cognitive decline by intervention arm overall.

Interventions may not impact cognitive decline rates, suggesting a need for alternative strategies.

Innovative therapeutics focused on hunger control are being considered for patients with rare genetic obesities.

Clinicians may consider new pharmacological options for managing hunger in patients with rare genetic obesities.

No significant difference in fatigue index for knee extensors and flexors was observed between acai supplementation and placebo.

Acai supplementation does not appear to affect fatigue levels in knee extensors and flexors post-exercise.

Diabetic neuropathy is associated with substantial morbidity, increased risk of mortality, and reduced quality of life.

Healthcare providers should recognize the serious implications of diabetic neuropathy on patient health.

Hypocretin-deficient male narcoleptic patients exhibit greater heart rate variability compared to controls (p = 0.01).

Increased heart rate variability may indicate altered autonomic function in narcoleptic patients.

The low to high frequency ratio of heart rate power does not differ between hypocretin-deficient narcoleptics and controls (p = 0.48).

The balance of autonomic control, as measured by this ratio, is similar in both groups.

The association between T2D subgroups and MCI/PD was not modified by the Action for Health in Diabetes (Look AHEAD) lifestyle intervention.

Lifestyle interventions may not be sufficient to alter cognitive decline risks in certain T2D subgroups.

Individuals in the younger onset T2D subgroup have the lowest risk for peripheral neuropathy.

Younger individuals with T2D may require different monitoring for PN risk.

The impact of intensive lifestyle intervention (ILI) on peripheral neuropathy risk does not differ by T2D subgroups.

ILI may not be effective in reducing PN risk across different T2D subgroups.